Skip to main content
. 2019 Oct;10(5):869–877. doi: 10.21037/jgo.2019.05.02

Table 1. Demographic and tumor related features of patients diagnosed between 2000 and 2014 at 18 SEER sites, and 2 and 5 years relative survival rates of each groups.

Variable Patients, n (%) RSR (2 years), % RSR (5 years), % P value
Overall 1,138 (100.00) 87.30±1.20 72.00±2.00
Age (years)
   ≤50 227 (19.95) 92.60±2.00 80.20±3.20 ref
   >50 911 (80.05) 86.20±1.40 70.20±2.20 0.006
Gender
   Male 589 (51.76) 86.20±1.70 71.70±2.70 ref
   Female 549 (48.24) 88.50±1.60 72.30±2.80 0.81
Year of diagnosis
   ≤2007 285 (25.04) 82.10±2.50 66.50±3.20 ref
   ≥2008 853 (74.96) 89.30±1.30 74.70±2.60 0.01
Race
   White 972 (85.41) 87.90±1.30 72.60±2.10 ref
   Black/others 166 (14.59) 85.00±3.50 72.00±5.40 0.43
Tumor location
   Duodenum 75 (6.59) 63.7±5.90 51.50±6.70 ref
   Jejunum 78 (6.85) 85.20±5.00 72.30±7.70 0.006
   Ileum 633 (55.62) 91.30±1.40 76.40±2.60 <0.001
   NOS 352 (30.93) 85.80±2.20 67.80±3.70 <0.001
Tumor size (cm)
   ≤2 419 (36.81) 89.90±1.20 74.80±2.20 ref
   >2 505 (44.37) 71.60±4.30 59.20±5.50 <0.001
   Missing 214 (18.80) NA NA NA
Histology
   Neuroendocrine 529 (46.49) 83.00±1.90 65.10±3.00 ref
   Carcinoid 580 (50.97) 92.60±1.40 79.30±2.60 <0.001
   Other 29 (2.55) 73.80±10.20 62.00±12.40 0.60
Liver metastasis
   No 203 (17.83) 87.80±3.10 NA ref
   Yes 464 (40.77) 88.90±1.80 NA 0.87
   Missing 471 (41.38) NA NA NA
Grade
   I 814 (71.53) 92.10±0.20 78.50±2.20 ref
   II 233 (20.47) 87.00±2.70 64.30±4.70 0.003
   III/IV 91 (8.00) 47.40±5.70 33.80±6.10 <0.001
Surgery
   No surgery 126 (11.07) 62.80±4.70 45.30±6.0 ref
   Local resection 750 (65.91) 91.20±1.30 76.00±2.40 <0.001
   Radical resection 262 (23.02) 88.20±2.30 73.70±3.70 <0.001

RSR, relative survival rate; ref, reference; NOS, not otherwise specified.